Canopy Growth Corporation (CGC)
Stock Price Chart
Key Info
| Market Cap | 6.09B |
| Revenue (ttm) | 275.02M |
| Net Income (ttm) | -956.86M |
| Shares Out | 368.99M |
| EPS (ttm) | -1.79 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Jul 2, 2020 |
| Last Price | $16.45 |
| Previous Close | $16.47 |
| Change ($) | -0.02 |
| Change (%) | -0.12% |
| Day's Open | 16.70 |
| Day's Range | 16.29 - 16.78 |
| Day's Volume | 2,043,687 |
| 52-Week Range | 9.00 - 41.07 |
More Stats
| Market Cap | 6.09B |
| Enterprise Value | 5.03B |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 368.99M |
| Float | 220.86M |
| EPS (basic) | n/a |
| EPS (diluted) | -1.79 |
| FCF / Share | -2.93 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 46.77M |
| Short Ratio | 5.30 |
| Short % of Float | n/a |
| Beta | 2.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 22.13 |
| PB Ratio | 1.71 |
| Revenue | 275.02M |
| Operating Income | -1.15B |
| Net Income | -956.86M |
| Free Cash Flow | -1.02B |
| Net Cash | 1.06B |
| Net Cash / Share | 2.86 |
| Gross Margin | -7.95% |
| Operating Margin | -418.53% |
| Profit Margin | -347.90% |
| FCF Margin | -370.53% |
| ROA | -7.11% |
| ROE | -22.65% |
| ROIC | -35.90% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 399 | 226 | 77.95 | 39.90 |
| Revenue Growth | 76.18% | 190.37% | 95.38% | - |
| Gross Profit | -31.68 | 28.25 | 32.99 | 38.71 |
| Operating Income | -1,669 | -637 | -120 | -14.08 |
| Net Income | -1,387 | -712 | -51.06 | -7.52 |
| Shares Outstanding | 348 | 267 | 177 | 119 |
| Earnings Per Share | -3.80 | -2.76 | -0.38 | -0.06 |
| Operating Cash Flow | -773 | -535 | -81.51 | -27.09 |
| Capital Expenditures | -705 | -644 | -176 | -29.50 |
| Free Cash Flow | -1,478 | -1,179 | -257 | -56.59 |
| Cash & Equivalents | 1,998 | 4,536 | 323 | 102 |
| Total Debt | 465 | 946 | 8.42 | 10.33 |
| Net Cash / Debt | 1,533 | 3,590 | 314 | 91.47 |
| Assets | 6,858 | 8,565 | 1,437 | 703 |
| Liabilities | 1,680 | 1,493 | 194 | 62.99 |
| Book Value | 5,108 | 7,066 | 1,159 | 640 |
Company Profile
Company Details
| Full Name | Canopy Growth Corporation |
| Country | Canada |
| Employees | 4,434 |
| CEO | David Eric Klein |
Stock Information
| Ticker Symbol | CGC |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | NYSE: CGC |
Description
Canopy Growth Corporation, together with its subsidiaries, engages in engages in production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, softgel capsules, and hemps. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of a mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.